Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

HealthStream, Inc. (HSTM) SEC Filings & Earnings Calls

EquiReason read 20 HealthStream, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-09-23 — HealthStream granted time-based and performance-based RSUs to named executive officers. Routine compensation grants with no change in leadership..

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

HSTMHealthStream, Inc.Follow HSTM — free
Health Information Services · Healthcare
—
Price chart with a free account
Market cap
1.0B
P/E TTM
48.8
Dividend yield
0.4%
52-week
—
Next earnings
26 Oct, in 2 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

23 Sep 20268-K · 5.02HealthStream granted time-based and performance-based RSUs to named executive officers. Routine compensation grants with no change in leadership.SEC ↗
21 Sep 2026SC 13DWJRJJ Ventures, LLC filed a Schedule 13D disclosing a 9.6% stake in HealthStream, including a $40M private placement and open market purchases, with standstill restrictions.SEC ↗
21 Sep 2026SC 13DSchedule 13D: WJRJJ Ventures, LLC 9.6%SEC ↗
15 Sep 20268-K · 1.01, 3.02, 7.01HealthStream entered into Securities Purchase Agreement with WJRJJ Ventures for sale of common stock. Includes registration rights. Selling shareholder Robert A. Frist, Jr. also selling shares. Unregistered sale of equity securities.open

Risks flagged

Dilution from issuance of new common shares; selling shareholder also participating, indicating insider monetization.

“Sale of common stock by both company and selling shareholder Robert A. Frist, Jr.”
Read the original on SEC EDGAR ↗
14 Sep 20268-K · 1.01, 2.03HealthStream entered into a Second Amendment to its Amended and Restated Revolving Credit Agreement with Truist Bank, modifying terms of existing credit facility. No specific financial details disclosed.SEC ↗
6 Aug 202610-QHealthStream reported Q2 2026 revenue of $83.7M (+12.5% YoY) and net income of $6.7M (+23.8% YoY), with strong subscription growth and margin expansion.earningsopen

Figures in the filing · each found in the filing text

Revenue · Q2-2026$84M+13% y/y
Net income · Q2-2026$7M+24% y/y
Adjusted EBITDA · Q2-2026$21M+17% y/y
Earnings per share (diluted) · Q2-2026$0.23
Capital expenditures · Q2-2026$8M
Days sales outstanding · Q2-202638

Risks flagged

Healthcare policy risk

“the federal budget reconciliation legislation enacted on July 4, 2025 includes significant policy changes that may adversely impact healthcare provider organizations, including changes that are expected to decrease access to health insurance and result in significant cuts to federal healthcare spending, particularly within the Medicaid program.” · word for word

Cybersecurity incident

“the Company detected that it had experienced a cybersecurity incident in which an unauthorized third party gained access to a limited portion of files on the Company’s corporate file server.” · word for word

Macroeconomic pressure on customers

“We believe that many of our customers have experienced increased labor, supply chain, capital, and other expenditures associated with recent inflationary pressures.” · word for word
Read the original on SEC EDGAR ↗
3 Aug 20268-K · 2.02, 7.01, 8.01Revenue $84M (+12% y/y); Operating income $8M (+41% y/y); Net income $7M (+24% y/y); Guidance: Updated guidance for full year 2026earningsopen

Figures in the filing · each found in the filing text

Revenue · Q2-2026$84M+13% y/y
Operating income · Q2-2026$8M+41% y/y
Net income · Q2-2026$7M+24% y/y
Earnings per share (diluted) · Q2-2026$0.23+28% y/y
Adjusted EBITDA · Q2-2026$21M+17% y/y

Guidance

Updated guidance for full year 2026

Updated guidance reflects strong performance; record revenue and profit growth.

Risks flagged

Higher expenses from acquisitions and investments may pressure margins.

“Higher personnel costs, third-party software, cloud hosting expenses.”
Read the original on SEC EDGAR ↗
29 Jul 20268-K · 8.01HealthStream detects cybersecurity incident with unauthorized access to corporate file server; employee and billing data potentially exfiltrated; no material impact expected.open

Risks flagged

Potential legal, reputational, and financial risks from cybersecurity incident.

“legal, reputational, and financial risks resulting from this cybersecurity incident” · word for word

Ongoing investigation may reveal additional impact.

“investigation, which remains ongoing” · word for word
Read the original on SEC EDGAR ↗
8 May 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)SEC ↗
6 May 202610-QRevenue $81M (+10% y/y); Net Income $6M (+36% y/y); Adjusted EBITDA $20M (+24% y/y)open

Figures in the filing · each found in the filing text

Revenue · Q1-2026$81M+11% y/y
Net Income · Q1-2026$6M+36% y/y
Adjusted EBITDA · Q1-2026$20M+24% y/y
Capital Expenditures · Q1-2026$8M-15% y/y
Operating Cash Flow · Q1-2026$27M+0% y/y
Days Sales Outstanding · Q1-202639+5% y/y
Subscription Revenue · Q1-2026$78M+11% y/y
Professional Services Revenue · Q1-2026$3M+4% y/y
Operating Income · Q1-2026$8M+72% y/y
Earnings Per Share (Diluted) · Q1-2026$0.20+43% y/y

Risks flagged

Healthcare Policy and Reimbursement Risk

“the federal budget reconciliation legislation enacted on July 4, 2025 includes significant policy changes that may adversely impact healthcare provider organizations, including changes that are expected to decrease access to health insurance and result in significant cuts to federal healthcare spending, particularly within the Medicaid program.” · word for word

Macroeconomic and Inflationary Pressure on Customers

“Macroeconomic challenges also persist in the United States in terms of inflationary pressures that have moderated from recent periods but continue to affect cost structures, ongoing elevated interest rate levels, heightened geopolitical tensions (including as a result of ongoing conflicts in the Middle East), and strained global trade relations.” · word for word

Customer Purchase Delays and Non-Renewals

“We believe that these challenges and uncertainties, particularly among healthcare provider organizations with patient populations more dependent on government-funded reimbursement, have caused, and may continue to cause, some delays in purchasing and non-renewals of our products and services, particularly in relation to elective or non-mandatory products and” · word for word
Read the original on SEC EDGAR ↗
4 May 20268-K · 2.02, 7.01, 8.01Revenue $81M (+10% y/y); Operating income $8M (+72% y/y); Net income $6M (+36% y/y)earningsopen

Figures in the filing · each found in the filing text

Revenue · Q1-2026$81M+11% y/y
Operating income · Q1-2026$8M+72% y/y
Net income · Q1-2026$6M+36% y/y
Earnings per share (diluted) · Q1-2026$0.20+43% y/y
Adjusted EBITDA · Q1-2026$20M+24% y/y

Guidance

Reaffirmed full-year 2026 guidance, supported by strong Q1 results and improved profitability.

Risks flagged

Higher expenses from investments in platform and enterprise applications may pressure margins if revenue growth slows.

“higher expenses in the first quarter of 2026 to support investments in several areas of the business, primarily in our platform and enterprise applications, resulting in higher labor costs, increased royalties expense, and higher cloud hosting and third-party software expenses” · word for word
Read the original on SEC EDGAR ↗
10 Apr 2026DEF 14AProxy statement filed for 2026 annual meeting, disclosing executive compensation structure and performance metrics.open

Figures in the filing · each found in the filing text

Revenue · FY2025$304M+4% y/y
Operating income · FY2025$20M-5% y/y
Net income · FY2025$18M-8% y/y
Adjusted EBITDA · FY2025$72M+8% y/y
Cash, cash equivalents, and marketable securities · 2025-12-31$57M
2025 Incentive Plan Company Adjusted EBITDA · FY2025$72M
2025 RSU Company Adjusted EBITDA · FY2025$72M
Shares outstanding · 2026-03-3029,421,632
Read the original on SEC EDGAR ↗
13 Mar 20268-K · 1.01, 8.01Board approved a new $10M share repurchase program; credit agreement amendment also permits additional restricted payments up to $50M, signaling capital return flexibility.open

Figures in the filing · each found in the filing text

Share repurchase authorization · March 2026$10M
Additional restricted payment capacity · March 2026$50M

Risks flagged

Increased leverage from share repurchases could strain balance sheet if earnings decline.

“Restricted payments allowed only if pro forma leverage ratio ≤1.50x and no default.”
Read the original on SEC EDGAR ↗
27 Feb 202610-KRevenue $304M (+4% y/y); Net income $18M (-8% y/y); Adjusted EBITDA $72M (+7% y/y)open

Figures in the filing · each found in the filing text

Revenue · FY2025$304M+4% y/y
Net income · FY2025$18M-8% y/y
Adjusted EBITDA · FY2025$72M+7% y/y
Capital expenditures · FY2025$32M+15% y/y
Operating cash flow · FY2025$63M+10% y/y
Days sales outstanding · FY2025$37.00-8% y/y
Earnings per share (diluted) · FY2025$0.61-8% y/y
Cash, cash equivalents, and marketable securities · FY2025$57M

Risks flagged

Healthcare policy cuts impacting customer budgets

“the federal budget reconciliation legislation enacted on July 4, 2025 includes significant policy changes that may adversely impact healthcare provider organizations, including changes that are expected to decrease access to health insurance and result in significant cuts to federal healthcare spending, particularly within the Medicaid program.” · word for word

Legacy product revenue decline

“revenues for the year ended December 31, 2025 grew by $23.4 million across our portfolio of solutions, including $1.6 million from the Virsys12 and MissionCare acquisitions, but were partially offset by a $9.3 million reduction from legacy applications and a $1.6 million reduction from customer bankruptcies.” · word for word
Read the original on SEC EDGAR ↗
23 Feb 20268-K · 2.02, 7.01, 8.01Revenue $80M (+7% y/y); Revenue $304M (+4% y/y); Operating income $2M (-49% y/y); Guidance: FY2026 guidance provided; dividend increased 12.9%earningsopen

Figures in the filing · each found in the filing text

Revenue · Q4-2025$80M+7% y/y
Revenue · FY2025$304M+4% y/y
Operating income · Q4-2025$2M-49% y/y
Non-GAAP operating income · Q4-2025$6M+32% y/y
Net income · Q4-2025$3M-48% y/y
Non-GAAP net income · Q4-2025$5M+10% y/y
Earnings per share (diluted) · Q4-2025$0.09-44% y/y
Non-GAAP EPS (diluted) · Q4-2025$0.18+13% y/y
Adjusted EBITDA · Q4-2025$19M+16% y/y
Adjusted EBITDA · FY2025$72M+8% y/y

Guidance

FY2026 guidance provided; dividend increased 12.9%

Management provided FY2026 guidance and raised dividend, signaling confidence in continued growth.

Risks flagged

CEO stock gift caused GAAP operating income decline; non-recurring but may confuse investors.

“Operating income down 48.8% due to $3.8M CEO Stock Gift charge.”

Acquisition integration risk from Virsys12 and MissionCare Collective acquisitions.

“Completed acquisitions of two companies: Virsys12 and MissionCare Collective.”
Read the original on SEC EDGAR ↗
15 Dec 20258-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen

Risks flagged

Integration risk from acquisition; no financial terms disclosed.

“No financial details or integration plan provided in the excerpt.”
Read the original on SEC EDGAR ↗
9 Dec 20258-K · 8.01CEO share contribution $4M; Additional cost contribution $275,000.00open

Figures in the filing · each found in the filing text

CEO share contribution · Q4-2025$4M
Additional cost contribution · Q4-2025$275000.00
Read the original on SEC EDGAR ↗
12 Nov 20258-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen

Risks flagged

Buyback may reduce financial flexibility if cash flow weakens.

“$10M buyback authorization.”
Read the original on SEC EDGAR ↗
6 Nov 202510-QHealthStream reported Q3 2025 revenue of $76.5M (+4.6% YoY), operating income of $7.6M (+16.5% YoY), and adjusted EBITDA of $19.1M (+7.9% YoY).earningsopen

Figures in the filing · each found in the filing text

Revenue · Q3-2025$77M+5% y/y
Net Income · Q3-2025$6M+6% y/y
Adjusted EBITDA · Q3-2025$19M+8% y/y
EPS (diluted) · Q3-2025$0.20+5% y/y
Operating Income · Q3-2025$8M+17% y/y
Operating Cash Flow · 9M-2025$50M+8% y/y
DSO · Q3-2025$33.00-11% y/y

Risks flagged

Healthcare Reimbursement Cuts

“the federal budget reconciliation legislation enacted on July 4, 2025 includes significant policy changes that may adversely impact healthcare provider organizations, including changes that are expected to decrease access to health insurance and result in significant cuts to federal healthcare spending, particularly within the Medicaid program.” · word for word

Government Shutdown Impact

“the federal government entered into a partial shutdown effective October 1, 2025. Although Medicare and Medicaid reimbursement generally remains available throughout a shutdown, our healthcare customers may experience delays in payment for services rendered and other effects related to government agencies operating at reduced capacity and lack of congression” · word for word

Expiration of Enhanced Premium Tax Credits

“enhanced premium tax credits for individuals eligible to purchase insurance coverage through federal and state-based health insurance marketplaces are scheduled to expire at the end of 2025, and further extension is uncertain. If these tax credits are not extended, this could reduce insurance coverage levels and indirectly influence customer budgets of our h” · word for word

Inflationary and Interest Rate Pressure

“Challenges also persist in terms of inflationary pressures, ongoing elevated interest rate levels, lower consumer sentiment levels compared to recent periods, and geopolitical tensions, including various ongoing and threatened conflicts abroad and strained global trade relations.” · word for word
Read the original on SEC EDGAR ↗
3 Nov 20258-K · 2.02, 7.01, 8.01Revenue $76M (+5% y/y); Operating income $8M (+16% y/y); Net income $6M (+6% y/y); Guidance: Updated guidance for full year 2025earningsopen

Figures in the filing · each found in the filing text

Revenue · Q3-2025$77M+5% y/y
Operating income · Q3-2025$8M+17% y/y
Net income · Q3-2025$6M+6% y/y
Earnings per share (diluted) · Q3-2025$0.20+5% y/y
Adjusted EBITDA · Q3-2025$19M+8% y/y
Cash, cash equivalents, and marketable securities · Q3-2025$93M
Capital expenditures · Q3-2025$8M

Guidance

Updated guidance for full year 2025

Guidance updated but details not fully provided in excerpt.

Risks flagged

Higher expenses for platform investments may pressure margins.

“Higher expenses to support investments in several areas of the business, primarily in our platform and SaaS applications, resulting in higher labor costs, higher cloud hosting and third-party software costs, and increased amortization of capitalized software costs.” · word for word
Read the original on SEC EDGAR ↗

HealthStream, Inc. — questions

What did HealthStream, Inc. file recently?
20 SEC filings in the last 12 months. Latest: 8-K on 2026-09-23 — HealthStream granted time-based and performance-based RSUs to named executive officers. Routine compensation grants with no change in leadership.

Every figure on this page comes from HealthStream, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.